Role of Nrf2 in chronic liver disease

被引:0
作者
Wei Tang [1 ]
Yong-Fang Jiang [1 ]
Murugavel Ponnusamy [2 ]
Mamadou Diallo [3 ]
机构
[1] Liver Diseases Research Center,The Second Xiangya Hospital, Central South University
[2] Department of Medicine, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, RI 02903, United States
[3] Department of Immunology and Infectious Diseases, Harvard School of Public Health, Harvard University,Boston, MA 02115-6018, United States
关键词
Nuclear erythroid 2-related factor 2; Chronic liver disease; Oxidative stress; Reactive oxygen species; Hepatic injury; Hepatic protection;
D O I
暂无
中图分类号
R575 [肝及胆疾病];
学科分类号
1002 ; 100201 ;
摘要
Nuclear erythroid 2-related factor 2(Nrf2) is a central regulator of antioxidative response elements-mediated gene expression. It has a significant role in adaptive responses to oxidative stress by interacting with the antioxidant response element, which induces the expression of a variety of downstream targets aimed at cytoprotection. Previous studies suggested oxidative stress and associated damage could represent a common link between different forms of diseases. Oxidative stress has been implicated in various liver diseases, including viral hepatitis, nonalcoholic fatty liver disease/steatohepatitis, alcoholic liver disease and drug-induced liver injury. Nrf2 activation is initiated by oxidative or electrophilic stress, and aids in the detoxification and elimination of potentially harmful exogenous chemicals and their metabolites. The expression of Nrf2 has been observed throughout human tissue, with high expression in detoxification organs, especially the liver. Thus, Nrf2 may serve as a major regulator of several cellular defense associated pathways by which hepatic cells combat oxidative stress. We review the relevant literature concerning the crucial role of Nrf2 and its signaling pathways against oxidative stress to protect hepatic cell from oxidative damage during development of common chronic liver diseases. We also review the use of Nrf2 as a therapeutic target to prevent and treat liver diseases.
引用
收藏
页码:13079 / 13087
页数:9
相关论文
共 28 条
  • [1] Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine[J]. Daniela Gordillo-Bastidas,Edén Oceguera-Contreras,Adriana Salazar-Montes,Jaime González-Cuevas,Luis Daniel Hernández-Ortega,Juan Armendáriz-Borunda.World Journal of Gastroenterology. 2013(47)
  • [2] Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells[J]. Lisa Rossi,Richard W Lambrecht,Herbert L Bonkovsky.World Journal of Gastroenterology. 2009(36)
  • [3] Analysis of changes in hepatic gene expression in a murine model of tolerance to acetaminophen hepatotoxicity (autoprotection)
    O'Connor, Meeghan A.
    Koza-Taylor, Petra
    Campion, Sarah N.
    Aleksunes, Lauren M.
    Gu, Xinsheng
    Enayetallah, Ahmed E.
    Lawton, Michael P.
    Manautou, Jose E.
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2014, 274 (01) : 156 - 167
  • [4] Molecular mechanisms of lipopolysaccharide-mediated inhibition of glutathione synthesis in mice[J] . Maria Lauda Tomasi,Minjung Ryoo,Heping Yang,Ainhoa Iglesias Ara,Kwang Suk Ko,Shelly C. Lu.Free Radical Biology and Medicine . 2014
  • [5] ER stress-induced cell death mechanisms[J] . Renata Sano,John C. Reed.BBA - Molecular Cell Research . 2013
  • [6] Betanin, a beetroot component, induces nuclear factor erythroid-2-related factor 2-mediated expression of detoxifying/antioxidant enzymes in human liver cell lines[J] . Violetta Krajka-Ku?niak,Jaros?aw Paluszczak,Hanna Szaefer,Wanda Baer-Dubowska.British Journal of Nutrition . 2013 (12)
  • [7] New Player on An Old Field; the Keap1/Nrf2 Pathway as a Target for Treatment of Type 2 Diabetes and Metabolic Syndrome
    Chartoumpekis, Dionysios V.
    Kensler, Thomas W.
    [J]. CURRENT DIABETES REVIEWS, 2013, 9 (02) : 137 - 145
  • [8] Carthamus red from Carthamus tinctorius L. exerts antioxidant and hepatoprotective effect against CCl 4 -induced liver damage in rats via the Nrf2 pathway[J] . Shuangchan Wu,Yuan Yue,Hui Tian,Zhike Li,Xiaofei Li,Wei He,Hong Ding.Journal of Ethnopharmacology . 2013 (2)
  • [9] Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation
    Cui, Yizhe
    Wang, Qiuju
    Li, Xiaochong
    Zhang, Xiuying
    [J]. REDOX BIOLOGY, 2013, 1 (01): : 433 - 440
  • [10] Nuclear Factor (Erythroid-Derived 2)-Like-2 Factor (Nrf2), a Key Regulator of the Antioxidant Response to Protect Against Atherosclerosis and Nonalcoholic Steatohepatitis[J] . Anisha A. Gupte,Christopher J. Lyon,Willa A. Hsueh.Current Diabetes Reports . 2013 (3)